Answers are grounded in this paper and cite their sources.
(See the Major Article by Bond et al on pages 1046–54.) In this issue of Clinical Infectious Diseases, a group long established in Kenema, Sierra Leone, and other partners (Bond et al [1]) report on the continued clinical experience of patients who were afflicted during that country’s 2014–6 Ebola virus disease epidemic. This work has 2 principal strengths. First, some of the patients assessed had more than 2 years of following. Second, rather than a by-symptom approach, the authors pursued a clinical syndrome analysis employing correlative and cluster methodologies to define symptom groups. Both aspects carry lessons for continued survivor research in emergent or pervasive infectious disease events, such as the ongoing coronavirus disease 2019 (COVID-19) pandemic. What being a survivor of Ebola virus disease (EVD) might mean was broadly of interest at the close of the West Africa emergency. This has not always been...
No takes yet. Share an insight, caveat, or question.
David M. Brett‐Major (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: